发明名称 LYOPHILIZED FORMULATION COMPRISING GM-CSF NEUTRALIZING COMPOUND
摘要 The present invention relates to aqueous formulations comprising at least 20 mg/ml of a compound neutralizing GM-CSF, a lyoprotectant and an amino acid and/or a buffer. The ingredients of the formulation preferably provide stability to the compound neutralizing GM-CSF in view of lyophilisation, storage and reconstruction. In a preferred aspect, the formulation, e.g. after reconstruction, is for use in therapy, preferably for use in the treatment of inflammatory and autoimmune disorders, preferably including allergic and psoriatic disorders, as well as arthritic and asthmatic disorders. Furthermore, a kit comprising the formulation of the invention is provided.
申请公布号 US2015342888(A1) 申请公布日期 2015.12.03
申请号 US201314428489 申请日期 2013.10.31
申请人 AMGEN RESEARCH (MUNICH) GMBH ;TAKEDA GMBH 发明人 Rast Markus;Steinhilber Wolfram;de Muynck Christian;Becker Gerhard;Pedersen Pernille Dybendal;Urbig Thomas;Boehm Thomas
分类号 A61K9/19;A61K47/22;C07K16/24;A61K47/26 主分类号 A61K9/19
代理机构 代理人
主权项 1. A composition comprising a compound neutralizing GM-CSF in a concentration of at least about 20 mg/ml, a lyo-protectant and an amino acid and/or a buffer.
地址 Munich DE